A Mother’s Gift of Hope
As a mother, there is no greater calling than to care for your child—and when my daughter Amy fell ill with ME/CFS nearly eight years ago, I knew I would do whatever it took to support her. Watching her go from a vibrant young woman to being house-bound was heartbreaking. Despite her physical suffering, Amy’s […]
From Ronald W. Davis, PhD: Community Symposium on the Molecular Basis of ME/CFS

In 2016, Open Medicine Foundation (OMF) hosted the first of four in-person ME/CFS Research and Community Symposiums at Stanford University, each drawing strong attendance. During the COVID-19 pandemic, the Research Symposium transitioned to a virtual format, expanding access for researchers worldwide. This year marks the 9th Annual Stanford Working Group Meeting on the Molecular Basis of ME/CFS. […]
🧬Science Wednesdays: Types of Biosamples

Types of Biosamples From the Desk of Dr. Danielle Meadows,Vice President of Research Programs & Operations Last month I talked more in depth about ethics review as a critical part of the first stage of the research process when conducting any study on human subjects. So this month, let’s move forward to the “Recruitment, Data […]
Now Available: IIMEC17 Conference Presentations
The 17th Invest in ME Research International ME Conference (IIMEC17) took place on May 30, 2025, in Cambridge, United Kingdom, marking the final event of International ME Conference Week 2025—a series of collaborative events featuring workshops, strategic meetings, and scientific sessions. As a major international forum, IIMEC17 brought together researchers, clinicians, and patient advocates dedicated […]
Steroid Dynamics in ME/CFS: New Publication
Today, we are pleased to share a new publication, Steroid Dynamics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Case-Control Study using Ultra Performance Supercritical Fluid Chromatography Tandem Mass Spectrometry. The Heart of the Matter OMF’s research centers in Uppsala and Melbourne published a study of steroid hormones—molecules that control a lot of important systems in the […]
🎥 Video Presentations: Insights from Dr. David Systrom
The Director of OMF’s Ronald G. Tompkins Harvard ME/CFS Collaboration, Dr. David Systrom, recently attended the International ME/CFS Conference 2025 held in Berlin, Germany. As part of the conference, he gave two presentations—one on circulatory dysfunction, and another on a randomized controlled trial of low-dose naltrexone and Mestinon in ME/CFS. In his presentation on circulatory […]
New Publication: OMF’s Collaborative Center at Montreal
We’re excited to share a new publication from OMF’s Collaborative Center at Montreal titled: “SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.” The Heart of the Matter The team at OMF’s Collaborative Center at Montreal published a paper that talks about their study of a molecule called SMPDL3B, which works differently in some […]
Update: Patient-Reported Treatment Outcomes in ME/CFS and Long COVID
From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations In the past, I’ve shared some information about the peer-review publication process—the last stage of the research process—and the concept of a preprint. We recognize that the publication process takes a long time, and we want to provide results and helpful information […]
🧬Science Wednesdays: What is an IRB or Ethics Board?

What is an IRB or Ethics Board? From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations The IRB plays a central role in the first stage of the research process—linked here again if you missed it—so it’s probably about time I talk about what an IRB (or the non-US equivalent) actually is […]
Update: A Muscle Biopsy Study to Understand the Molecular Mechanisms of PEM
From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations Today, I’m happy to share another update on a study that I introduced back in November 2024 in an interview with Dr. Systrom. The study is still going on, but in this case, we’re able to share some exciting preliminary data. We […]